News
My role is to ensure they can transition seamlessly from clinic to classroom, allowing them to focus on what truly matters: ...
10d
Clinical Trials Arena on MSNEmory begins enrolment for BioCardia’s trial of ischemic heart failure therapyThe trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.
SUNNYVALE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
For the third straight year, the U.S. News & World Report (USNWR) ranked Emory University’s Nell Hodgson Woodruff School of Nursing master’s program as No. 1. On April 8, USNWR released its rankings ...
Emory University confers degrees through various schools, such as: the Goizueta Business School, the School of Law, the School of Medicine, and the Nell Hodgson Woodruff School of Nursing.
BioCardia (BCDA) announced that Emory University School of Medicine in Atlanta Georgia is now enrolling patients with ischemic heart failure in ...
Medical Xpress on MSN20d
New Emory research may revolutionize how stroke, heart attack, related blood-clotting conditions are treatedand assistant professor in the Department of Pediatrics at Emory University School of Medicine. For this study, Qiu also developed the hydrogel for this model using human blood in a human vein, making ...
CardiAMP HF II is Evaluating the CardiAMPâ„¢ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction ...
Department of Medicine, Emory University School of Medicine, and Co-Director of the Emory Clinical Cardiovascular Research Institute to Serve as Principal Investigator SUNNYVALE, Calif., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results